Pfizer Ventures (us) Llc - Net Worth and Insider Trading

Over the past 18 months, Pfizer Ventures (us) Llc made no insider transaction in Quince Therapeutics Inc (QNCX). Other recent insider transactions involving Quince Therapeutics Inc (QNCX) include a net purchase of 500,436 shares made by David Lamond , a net purchase of 168,000 shares made by Dirk Thye , and a net purchase of 71,762 shares made by Brendan Hannah .

In summary, during the past 3 months, insiders sold 0 shares of Quince Therapeutics Inc (QNCX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,871 shares of Quince Therapeutics Inc (QNCX) were sold and 748,198 shares were bought by its insiders, resulting in a net purchase of 746,327 shares.

Quince Therapeutics Inc (QNCX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Pfizer Ventures (us) Llc made no insider transaction in Imara Inc (IMRA). Other recent insider transactions involving Imara Inc (IMRA) include a net sale of 2,590,000 shares made by Braden Michael Leonard , a net purchase of 29,899 shares made by Ra Capital Healthcare Fund Lp , and a net sale of 11,313 shares made by Rahul D. Ballal .

In summary, during the past 3 months, insiders sold 0 shares of Imara Inc (IMRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,604,909 shares of Imara Inc (IMRA) were sold and 29,899 shares were bought by its insiders, resulting in a net sale of 2,575,010 shares.

Imara Inc (IMRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Pfizer Ventures (us) Llc made no insider transaction in SpringWorks Therapeutics Inc (SWTX). Other recent insider transactions involving SpringWorks Therapeutics Inc (SWTX) include a net sale of 42,039 shares made by Daniel Pichl , a net sale of 4,818 shares made by Julie Hambleton , and a net sale of 1,750,000 shares made by Jeffrey Lawrence Schwartz .

In summary, during the past 3 months, insiders sold 49,237 shares of SpringWorks Therapeutics Inc (SWTX) in total and bought 0 shares, with a net sale of 49,237 shares. During the past 18 months, 1,804,913 shares of SpringWorks Therapeutics Inc (SWTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,804,913 shares.

SpringWorks Therapeutics Inc (SWTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Pfizer Ventures (us) Llc made no insider transaction in BioAtla Inc (BCAB). Other recent insider transactions involving BioAtla Inc (BCAB) include a net purchase of 15,700 shares made by Sylvia Mcbrinn , a net purchase of 90,800 shares made by Short Jay M Phd , and a net purchase of 27,495 shares made by Christian Vasquez .

In summary, during the past 3 months, insiders sold 0 shares of BioAtla Inc (BCAB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BioAtla Inc (BCAB) were sold and 153,995 shares were bought by its insiders, resulting in a net purchase of 153,995 shares.

BioAtla Inc (BCAB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Pfizer Ventures (us) Llc made no insider transaction in Pyxis Oncology Inc (PYXS). Other recent insider transactions involving Pyxis Oncology Inc (PYXS) include a net purchase of 31,426 shares made by Pamela Ann Connealy , a net purchase of 10,000 shares made by Jitendra Wadhane , and a net purchase of 3,623,188 shares made by Pfizer Inc .

In summary, during the past 3 months, insiders sold 0 shares of Pyxis Oncology Inc (PYXS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 36,558 shares of Pyxis Oncology Inc (PYXS) were sold and 3,664,614 shares were bought by its insiders, resulting in a net purchase of 3,628,056 shares.

Pyxis Oncology Inc (PYXS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Pfizer Ventures (us) Llc made no insider transaction in Enliven Therapeutics Inc (ELVN). Other recent insider transactions involving Enliven Therapeutics Inc (ELVN) include a net sale of 131,709 shares made by Samuel Kintz , a net sale of 114,000 shares made by Joseph P Lyssikatos , and a net sale of 51,625 shares made by Anish Patel .

In summary, during the past 3 months, insiders sold 1,636,358 shares of Enliven Therapeutics Inc (ELVN) in total and bought 0 shares, with a net sale of 1,636,358 shares. During the past 18 months, 2,418,854 shares of Enliven Therapeutics Inc (ELVN) were sold and 622 shares were bought by its insiders, resulting in a net sale of 2,418,232 shares.

Enliven Therapeutics Inc (ELVN)'s detailed insider trading history can be found in Insider Trading Tracker table.